Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep160 | Calcium and Bone | ECE2023

Primary hyperparathyroidism: A rare form of presentation

Lopes Marta Vaz , Rocha Jose Vicente , Peixe Carolina , de Grine Severino Mariana , Gomes Ana Coelho , Bugalho Maria Joao

Introduction: Primary hyperparathyroidism (PHPT) is characterized by parathyroid hormone (PTH) overproduction, causing hypercalcemia. The most common cause is a parathyroid adenoma. PHPT most frequently presents as asymptomatic hypercalcemia or with nonspecific symptoms. Less frequently, it presents with the classical manifestations of bone disease and nephrolithiasis. Acute pancreatitis (AP) as the initial manifestation of PHPT has been reported rarely. Hypercalcemia can caus...

ea0056p739 | Growth hormone IGF axis - basic | ECE2018

Craniofacial fibrous dysplasia and long-term untreated GH excess in McCune–Albright syndrome

Lecumberri Beatriz , Gomes Mariana , Kreilinger Jose Juan Pozo , Esteban Isabel , Royo Arantxa , Perez de Nanclares Guiomar , Gomez de la Riva Alvaro

Introduction: Craniofacial fibrous dysplasia, characteristic of McCune-Albright syndrome (MAS), is usually present in patients with MAS related GH excess, and complicates their neurosurgical approach. We describe a 21-year-old male with severe craniofacial fibrous dysplasia and acute obstructive hydrocephalus due to a 39×35 mm cystic lesion in the third ventricle that occluded Monro’s foramina, in whom MAS and long-term untreated acromegaly were discovered.<p cla...

ea0073aep504 | Pituitary and Neuroendocrinology | ECE2021

Acromegaly: Knowing the enemy in order to win

Porras Mariana Gomes , Alexa Benítez Valderrama , Paola Parra Ramírez , Rosa García Moreno , Rojas Patricia Martin , Gumersindo Fernández Vázquez , Beatriz Lecumberri Santamaría , Cristina Álvarez Escolá

IntroductionAcromegaly is an uncommon chronic disease with an insidious course. Due to the high morbimortality it causes, its early diagnosis and treatment are priority. The three therapeutic pillars are surgery, pharmacological treatment and radiotherapy, alone or in combination.ObjectivesTo clinically, biochemically and histologically characterize patients with acromegaly under follow-up in a tertiary hospi...

ea0073aep478 | Pituitary and Neuroendocrinology | ECE2021

Uncured acromegaly, the dark side of the moon: a cross- sectional study

Porras Mariana Gomes , Alexa Benítez Valderrama , Álvaro Zamarrón Pérez , Carlos Pérez López , Isabel Esteban Rodríguez , Rosa García Moreno , Beatriz Lecumberri Santamaría , Cristina Álvarez Escolá

IntroductionAlthough surgical treatment of acromegaly is the treatment of choice in most patients, a wide therapeutic arsenal is available. Medical treatment can be indicated as primary treatment, complementary and even as pre-operative treatment.ObjectivesTo determine the prevalence of uncured acromegaly and the prevalence of controlled disease within this group. To clinically, biochemically and histological...

ea0073aep531 | Pituitary and Neuroendocrinology | ECE2021

Transsphenoidal surgery in acromegaly: Experience in a tertiary hospital

Alexa Pamela Benítez Valderrama , Porras Mariana Gomes , Carlos Pérez López , Álvaro Zamarrón Pérez , Rosa María García Moreno , Lecumberri Beatriz , Marcelino Pérez Álvarez , Cristina Álvarez Escolá

BackgroundAcromegaly is an infrequent chronic multisystemic disease associated with a significant morbidity and mortality rate. The treatment of choice is transsphenoidal surgery (TSS) because of its low risk of mortality and few complications.AimsTo determine the cure prevalence after TSS of growth hormone (GH) secreting pituitary adenomas. To analyze the predictive factors of non-remission after the surgery...